GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q1 2020

Top Holdings44 positions

Checking export access…
Activity:
TAKTAK
ADR

TAKEDA PHARMACEUTICAL CO LTD

20M$302.9M8.2%$18.88-22.52%
5 qtrssince 2019-Q1
Decreased
0

TENET HEALTHCARE CORP

19.7M$284.2M7.7%$17.82-19.17%
6 qtrssince 2018-Q4
Unchanged
0

CIGNA CORP NEW

1.5M$260.1M7.1%$157.88+0.96%
6 qtrssince 2018-Q4
Decreased
0

BAUSCH HEALTH COS INC

16.6M$257.6M7.0%$22.43-32.01%
6 qtrssince 2018-Q4
Unchanged
0

HCA HEALTHCARE INC

2.8M$252.7M6.9%$119.49-27.25%
6 qtrssince 2018-Q4
Decreased
0

MCKESSON CORP

1.6M$222.1M6.0%$105.01+26.61%
6 qtrssince 2018-Q4
Decreased
0

IQVIA HLDGS INC

1.7M$184.9M5.0%$115.32-2.03%
6 qtrssince 2018-Q4
Decreased
0

FMC CORP

1.9M$158.7M4.3%$52.60+32.60%
6 qtrssince 2018-Q4
Decreased
0

DXC TECHNOLOGY CO

11M$143.4M3.9%$51.14-74.48%
6 qtrssince 2018-Q4
Unchanged
0
HOLXHOLXDelisted

HOLOGIC INC

3.9M$137.3M3.7%$43.06-18.72%
6 qtrssince 2018-Q4
Decreased
0
PARAPARADelisted

PARAMOUNT GLOBAL

9.3M$130.1M3.5%——
2 qtrssince 2019-Q4
Decreased
0

HUMANA INC

335,945$105.5M2.9%$250.99+18.06%
6 qtrssince 2018-Q4
Decreased
0
NUANNUANDelisted

NUANCE COMMUNICATIONS INC

6.1M$102.6M2.8%——
6 qtrssince 2018-Q4
Decreased
0

FLEX LTD

11.7M$98.4M2.7%$6.33-0.04%
6 qtrssince 2018-Q4
Decreased
0

MERITOR INC

7.2M$95.5M2.6%——
6 qtrssince 2018-Q4
Unchanged
0

FISERV INC

839,208$79.7M2.2%$102.61-4.17%
3 qtrssince 2019-Q3
Decreased
0

BOSTON SCIENTIFIC CORP

2.4M$77.9M2.1%$32.630.00%
1 qtr
New
78

UNITEDHEALTH GROUP INC

281,705$70.3M1.9%$221.30+3.41%
4 qtrssince 2019-Q2
Decreased
0

AMERISOURCEBERGEN CORP

738,000$65.3M1.8%$66.46+13.98%
6 qtrssince 2018-Q4
Decreased
0

CENTENE CORP DEL

941,457$55.9M1.5%$52.76+12.60%
5 qtrssince 2019-Q1
Decreased
0
$3.7B
AUM
44
Positions
Q1 2020
Filing
HI score · 3.0/5
Quarterly 13F Value Change
+9%Q1'19$11.2B-2%Q2'19$11B-14%Q3'19$9.5B+20%Q4'19$11.4B-68%Q1'20$3.7B
Activity profile
$ moved · Q1'20
New3%Increased1%Decreased74%Exited23%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.3 quarters
<1Q16%1-4Q25%1-2Y59%2Y+0%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $3.7B across 44 positions as of Q1 2020. Top holdings: TAK (8.2%), THC (7.7%), CI (7.1%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q1 2020 Summary

Active quarter - 8 new positions, 14 exits, 4 increased. Top move: BSX (NEW, conviction 78). Portfolio: $3.7B across 44 positions.

Top holdings by portfolio weight

Total AUM$4B
TAK8.24%
THC7.73%
CI7.07%
BHC7.00%
HCA6.87%
MCK6.04%
IQV5.03%
FMC4.31%
DXC3.90%
HOLX3.73%
Other3.54%

Portfolio allocation by GICS sector

Sectors7
Healthcare68.36%
Unknown12.24%
Technology7.51%
Basic Materials6.17%
Industrials3.84%
Communication Services1.13%
Consumer Cyclical0.76%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L67
Conviction48
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PMTS INC
Q2 2025 → Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAmazon.com, Inc.
Q3 2025 → Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 → Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used